Buprenorphine Treatment Centers in New York

New York had 6,330 drug overdose deaths in 2023 — a 31.1-per-100,000 age-adjusted rate — and New York City operates one of the largest methadone networks in the United States, while New York State runs the country's most comprehensive single-payer behavioral-health regulatory framework through the Office of Addiction Services and Supports (OASAS). NWVCIL's directory tracks 548 buprenorphine providers in New York, with 65 in Manhattan, 46 in Brooklyn, and 36 in the Bronx — meaning roughly a quarter of all buprenorphine providers tracked nationally on this site are in greater NYC. New York Medicaid covers MAT without prior authorization under a dual managed-care / fee-for-service structure, and OASAS licenses 101 SAMHSA-certified Opioid Treatment Programs under 14 NYCRR Part 822 — by far the largest OTP network of any state. 584 of the 629 verified facilities in our directory accept Medicaid, and 512 offer telehealth. For New York residents starting buprenorphine, common pathways include: walking into an OASAS-licensed clinic in NYC, Buffalo, Rochester, Syracuse, or Albany (most major cities have multiple low-barrier options), a private MAT practice in any of the state's regions, a Federally Qualified Health Center for Medicaid or sliding-fee patients, or a telehealth visit with a New York-licensed prescriber. Most providers can prescribe Suboxone, Subutex, Zubsolv, or the monthly Sublocade injection. The HOPEline (1-877-846-7369) and OASAS's HOPEline-Text are run by the state for confidential support and treatment referral; SAMHSA's national helpline (1-800-662-4357) and the 988 Suicide and Crisis Lifeline are also available 24/7.